₹4,736.4
▲ +29.18 +0.62%
As of 27 Jul 2026 · delayed
NSE Listed
Sanofi Consumer Healthcare India Ltd. (SANOFICONR)
Volume: 4,106Avg Vol 1W: 5,032.6Avg Vol 1M: 8,295.7552W Range:₹3,975₹5,512
Key Ratios
Checked 1d agoMarket Cap₹10,430 Cr
Current Price₹4,736.4
Previous Close₹4,707.22
High / Low (52w)₹5,512 / ₹3,975
Volume4,106
Avg Vol (1W)5,032.6
Avg Vol (1M)8,295.75
Stock P/E43.36
Book Value₹166.96
Dividend Yield—
ROE73.1%
ROA—
Revenue (TTM)₹897 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹104.39
P/B27.11
Debt / Equity0.07
50 DMA₹4,640.17
200 DMA₹4,536.57
Day change+0.62%
Price Chart
₹4,736.4▼ 5.29% · 1Y
2025-07-292026-07-27
20-day avg volume: 8K shares
Pros
- Healthy return on equity of 73.1%.
- Company is almost debt-free.
Cons
- Revenue fell 24% YoY.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹160 Cr | ₹171 Cr | ₹173 Cr | ₹221 Cr | ₹234 Cr | ₹251 Cr | ₹229 Cr | ₹236 Cr |
| EBITDA | ₹66 Cr | ₹66 Cr | ₹67 Cr | ₹73 Cr | ₹85 Cr | ₹91 Cr | ₹91 Cr | ₹92 Cr |
| Net Profit | ₹45 Cr | ₹44 Cr | ₹50 Cr | ₹61 Cr | ₹63 Cr | ₹67 Cr | ₹68 Cr | ₹69 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | ₹560 Cr | ₹738 Cr | ₹897 Cr |
| EBITDA | ₹221 Cr | ₹279 Cr | ₹316 Cr |
| Net Profit | ₹165 Cr | ₹181 Cr | ₹240 Cr |
| EPS | 71.6 | 78.59 | 104.27 |
Balance Sheet
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | ₹345 Cr | ₹431 Cr | ₹547 Cr |
| Total Liabilities | ₹138 Cr | ₹158 Cr | ₹163 Cr |
| Equity | ₹208 Cr | ₹273 Cr | ₹384 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating | ₹4 Cr | ₹563 Cr | ₹262 Cr |
| Investing | ₹0 Cr | ₹2 Cr | ₹8 Cr |
| Financing | ₹2 Cr | ₹-116 Cr | ₹-134 Cr |
| Free Cash Flow | ₹4 Cr | ₹563 Cr | ₹262 Cr |
Shareholding
Promoter 71.27% Institutions 20.45% Public 8.27%
Efficiency & Working Capital
ROCE88.2%
Interest Coverage161.2
Dividend Payout—
Debtor Days12 d
Inventory Days26 d
Payable Days33 d
Cash Conversion Cycle5 d
Working Capital Days38 d
Shareholding Details
As of 2026-06-30
Promoter71.3%
FII2.6%
DII17.9%
Institutions20.5%
Public8.3%
Promoter Pledge0%
No. of Shareholders47,511
Shareholding Pattern
Quarterly — figures in %. Latest 11 quarters.
| Period | Jun 2024 | Sept 2024 | Oct 2024 | Oct 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 71.3% | 71.3% | 71.3% | 71.3% | 71.3% |
| FIIs | 6% | 5.2% | 4.9% | 4.9% | 4.4% | 4.5% | 3.2% | 2.9% | 2.8% | 2.8% | 2.6% |
| DIIs | 20.9% | 24% | 24.5% | 24.5% | 25.4% | 25.5% | 16.9% | 17.2% | 17.3% | 17.6% | 17.9% |
| Public | 12.7% | 10.4% | 10.2% | 10.2% | 9.8% | 9.6% | 8.6% | 8.6% | 8.6% | 8.4% | 8.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 61,091 | 58,582 | 57,598 | 57,598 | 55,734 | 51,859 | 49,632 | 48,808 | 48,075 | 48,418 | 47,511 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202512 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Opella Healthcare Participations B.v. | Shareholding of Promoter and Promoter Group | 60.4% | 1.39 Cr |
| Opal Bidco Sas | Shareholding of Promoter and Promoter Group | 10.9% | 25,04,630 |
| Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap Fund | Public Shareholding | 5.2% | 12,00,657 |
| Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Large Cap Fund | Public Shareholding | 3% | 6,96,684 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 2.1% | 4,88,448 |
| Icici Prudential Smallcap Fund | Public Shareholding | 1.6% | 3,61,041 |
| Sbi Dividend Yield Fund | Public Shareholding | 1.5% | 3,37,988 |
| General Insurance Corporation Of India | Public Shareholding | 1.3% | 2,99,998 |
| Bajaj Life Insurance Limited | Public Shareholding | 1.1% | 2,44,945 |
| Hoechst Gmbh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Opella Heathcare Sas, France | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Winthrop Pharma Tunisie | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Egypt Llc | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Slovakia S.r.o | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi Vietnam | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Opella Canada Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Gulf Fze | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Korea Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Philippines Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sa Healthcare Pty Australia | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Austria Gmbh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Belgium Nv/sa | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Czech S.r.o. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Oh Commercial K.f.t. | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Amit Jain | Chairman & Independent Directo | 2024 |
| Himanshu Bakshi | Executive Director & MD | 2024 |
| Maithilee Kaizad Mistry | Executive Director / Whole Time Director / CFO | 2024 |
| Carol-Ann Stewart | Non-Exec & Non-Independent Dir | 2024 |
| Stanislas Camart | Non-Exec & Non-Independent Dir | 2024 |
| Shobinder Duggal | Independent Non Exe. Director | 2024 |
| Suparna Pandhi | Independent Non Exe. Director | 2024 |
| Nikunjkumar Savaliya | CS / Compliance Officer / Legal Head | 2024 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Consumer Healthcare Products | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹715 Cr | 81.4% |
| Outside India | ₹164 Cr | 18.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 24 | 23 | 23 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-28 | Board Meetings | — |
| dividend | 2026-06-19 | ₹75.0 (750.0%) | Final |
| dividend | 2026-06-19 | ₹75 (750%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
5 recent disclosure(s)
Opal Bidco SASAcquisition · 25,04,630
Opella Healthcare Participations B.V.Acquisition · 4,865
SanofiDisposal · 4,865
Opella Healthcare Participations B.V.Acquisition · 1,39,04,722
Hoechst GmbHDisposal · 1,39,04,722
Substantial Acquisitions (SAST)
7 disclosure(s)
Open Offer11/06/2025 · 25,04,630
Inter-se Transfer25/10/2024 · 4,865
-10/10/2024 · 4,865
Inter-se Transfer10/10/2024 · 1,39,04,722
-10/10/2024 · 1,39,04,722
Inter-se Transfer10/10/2024 · 1,39,04,722
Company Information
🌐 www.sanofi.in ↗
📍 3rd Floor Sanofi House CTS, 117-B L&T Business Park Powai, Mumbai, Maharashtra, 400072
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sandur Manganese & Iron Ores Ltd.Sangam (India) Ltd.Sangani Hospitals LimitedSanghvi Movers Ltd.Sanginita Chemicals Ltd.Sanofi India LimitedSansera Engineering Ltd.Sanstar LimitedSanwaria Consumer LimitedSapphire Foods India Ltd.Shree Ajit Pulp & Paper LimitedSarda Energy & Minerals Ltd.All “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search